HEADER OXIDOREDUCTASE 13-AUG-02 1MFP TITLE E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND SB611113 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL REDUCTASE, NADH-DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FABI, ENOYL REDUCTASE, ENOYL-ACP REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.SEEFELD,W.H.MILLER,K.A.NEWLANDER,W.J.BURGESS,W.E.DEWOLF JR., AUTHOR 2 P.A.ELKINS,M.S.HEAD,D.R.JAKAS,C.A.JANSON,P.M.KELLER,P.J.MANLEY, AUTHOR 3 T.D.MOORE,D.J.PAYNE,S.PEARSON,B.J.POLIZZI,X.QIU,S.F.RITTENHOUSE, AUTHOR 4 I.N.UZINSKAS,N.G.WALLIS,W.F.HUFFMAN REVDAT 3 13-JUL-11 1MFP 1 VERSN REVDAT 2 24-FEB-09 1MFP 1 VERSN REVDAT 1 06-MAY-03 1MFP 0 JRNL AUTH M.A.SEEFELD,W.H.MILLER,K.A.NEWLANDER,W.J.BURGESS, JRNL AUTH 2 W.E.DEWOLF JR.,P.A.ELKINS,M.S.HEAD,D.R.JAKAS,C.A.JANSON, JRNL AUTH 3 P.M.KELLER,P.J.MANLEY,T.D.MOORE,D.J.PAYNE,S.PEARSON, JRNL AUTH 4 B.J.POLIZZI,X.QIU,S.F.RITTENHOUSE,I.N.UZINSKAS,N.G.WALLIS, JRNL AUTH 5 W.F.HUFFMAN JRNL TITL INDOLE NAPHTHYRIDINONES AS INHIBITORS OF BACTERIAL ENOYL-ACP JRNL TITL 2 REDUCTASES FABI AND FABK JRNL REF J.MED.CHEM. V. 46 1627 2003 JRNL REFN ISSN 0022-2623 JRNL PMID 12699381 JRNL DOI 10.1021/JM0204035 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 923 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE : 0.4290 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 48 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3836 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 149 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MFP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016876. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19201 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.330 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 69.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 28.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.07700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NAD+, HEPES, AMMONIUM SULFATE, PEG REMARK 280 400, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 108.49333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 216.98667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 162.74000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 271.23333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.24667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 108.49333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 216.98667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 271.23333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 162.74000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 54.24667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 23780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -164.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 39.80000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 68.93562 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 271.23333 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 MET B 1001 REMARK 465 GLU B 1260 REMARK 465 LEU B 1261 REMARK 465 LYS B 1262 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 180 O HOH A 382 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 144 CA - CB - CG ANGL. DEV. = -14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 63 112.35 -162.70 REMARK 500 LEU A 100 49.16 -99.30 REMARK 500 ASN A 155 -25.32 74.82 REMARK 500 ASN A 157 -122.25 39.14 REMARK 500 LYS A 201 -144.18 -177.23 REMARK 500 VAL A 247 72.63 -113.76 REMARK 500 LEU B1100 52.58 -110.76 REMARK 500 SER B1121 -55.84 -121.71 REMARK 500 ASN B1155 -25.79 79.39 REMARK 500 ASN B1157 -116.21 31.46 REMARK 500 ARG B1193 99.62 -68.41 REMARK 500 ALA B1196 -0.42 -48.67 REMARK 500 SER B1198 -18.02 -41.90 REMARK 500 LYS B1201 -154.28 46.43 REMARK 500 ASP B1202 43.73 -93.52 REMARK 500 VAL B1247 71.92 -113.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR B1022 0.07 SIDE CHAIN REMARK 500 TYR B1122 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IDN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IDN B 1302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C14 RELATED DB: PDB REMARK 900 1C14 IS THE SAME PROTEIN COMPLEXED WITH TRICLOSAN. REMARK 900 RELATED ID: 1I2Z RELATED DB: PDB REMARK 900 1I2Z IS THE SAME PROTEIN COMPLEXED WITH BRL-12654. REMARK 900 RELATED ID: 1I30 RELATED DB: PDB REMARK 900 1I30 IS THE SAME PROTEIN COMPLEXED WITH SB385826. DBREF 1MFP A 1 262 UNP P29132 FABI_ECOLI 0 261 DBREF 1MFP B 1001 1262 UNP P29132 FABI_ECOLI 0 261 SEQRES 1 A 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 A 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 A 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 A 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 A 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 A 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 A 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 A 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 A 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 A 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 A 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 A 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 A 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 A 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 A 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 A 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 A 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 A 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 A 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 A 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 A 262 LEU LYS SEQRES 1 B 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 B 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 B 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 B 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 B 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 B 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 B 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 B 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 B 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 B 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 B 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 B 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 B 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 B 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 B 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 B 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 B 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 B 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 B 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 B 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 B 262 LEU LYS HET SO4 B1303 5 HET NAD A 301 44 HET NAD B1301 44 HET IDN A 302 28 HET IDN B1302 28 HETNAM SO4 SULFATE ION HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM IDN (E)-N-METHYL-N-(1-METHYL-1H-INDOL-3-YLMETHYL)-3-(7-OXO- HETNAM 2 IDN 5,6,7,8-TETRAHYDRO-[1,8]NAPHTHYRIDIN-3-YL)-ACRYLAMIDE HETSYN IDN INDOLE NAPHTHYRIDINONE FORMUL 3 SO4 O4 S 2- FORMUL 4 NAD 2(C21 H27 N7 O14 P2) FORMUL 6 IDN 2(C22 H22 N4 O2) FORMUL 8 HOH *195(H2 O) HELIX 1 1 SER A 19 GLU A 31 1 13 HELIX 2 2 ASN A 41 LYS A 43 5 3 HELIX 3 3 LEU A 44 GLN A 54 1 11 HELIX 4 4 GLU A 67 TRP A 82 1 16 HELIX 5 5 PRO A 96 ASP A 101 5 6 HELIX 6 6 ASP A 103 VAL A 108 1 6 HELIX 7 7 THR A 109 SER A 121 1 13 HELIX 8 8 SER A 121 ARG A 132 1 12 HELIX 9 9 SER A 133 LEU A 135 5 3 HELIX 10 10 TYR A 146 GLU A 150 5 5 HELIX 11 11 ASN A 157 GLY A 178 1 22 HELIX 12 12 PRO A 179 GLY A 181 5 3 HELIX 13 13 THR A 194 SER A 198 5 5 HELIX 14 14 ASP A 202 THR A 214 1 13 HELIX 15 15 THR A 221 CYS A 233 1 13 HELIX 16 16 SER A 234 ALA A 238 5 5 HELIX 17 17 GLY A 250 ALA A 254 5 5 HELIX 18 18 SER B 1019 GLU B 1031 1 13 HELIX 19 19 ASN B 1041 LEU B 1055 1 15 HELIX 20 20 GLU B 1067 TRP B 1082 1 16 HELIX 21 21 PRO B 1096 ASP B 1101 5 6 HELIX 22 22 ASP B 1103 VAL B 1108 1 6 HELIX 23 23 THR B 1109 SER B 1121 1 13 HELIX 24 24 SER B 1121 ARG B 1132 1 12 HELIX 25 25 SER B 1133 LEU B 1135 5 3 HELIX 26 26 TYR B 1146 GLU B 1150 5 5 HELIX 27 27 TYR B 1156 GLY B 1178 1 23 HELIX 28 28 THR B 1194 GLY B 1199 1 6 HELIX 29 29 ASP B 1202 THR B 1214 1 13 HELIX 30 30 THR B 1221 CYS B 1233 1 13 HELIX 31 31 SER B 1234 ALA B 1238 5 5 HELIX 32 32 GLY B 1250 ALA B 1254 5 5 SHEET 1 A 7 VAL A 60 GLN A 62 0 SHEET 2 A 7 GLU A 34 TYR A 39 1 N PHE A 37 O LEU A 61 SHEET 3 A 7 ARG A 8 VAL A 11 1 N VAL A 11 O ALA A 36 SHEET 4 A 7 PHE A 88 HIS A 90 1 O VAL A 89 N LEU A 10 SHEET 5 A 7 ALA A 140 SER A 145 1 O LEU A 142 N HIS A 90 SHEET 6 A 7 ARG A 183 ALA A 189 1 O ILE A 187 N SER A 145 SHEET 7 A 7 VAL A 244 VAL A 247 1 O VAL A 245 N ALA A 186 SHEET 1 B 7 VAL B1060 GLN B1062 0 SHEET 2 B 7 GLU B1034 TYR B1039 1 N PHE B1037 O LEU B1061 SHEET 3 B 7 ARG B1008 VAL B1011 1 N VAL B1011 O ALA B1036 SHEET 4 B 7 PHE B1088 HIS B1090 1 O VAL B1089 N LEU B1010 SHEET 5 B 7 SER B1139 SER B1145 1 O LEU B1142 N HIS B1090 SHEET 6 B 7 VAL B1182 ALA B1189 1 O ILE B1187 N SER B1145 SHEET 7 B 7 VAL B1244 VAL B1247 1 O VAL B1245 N SER B1188 SITE 1 AC1 7 HOH B 27 HOH B 84 HOH B 168 LYS B1045 SITE 2 AC1 7 ASP B1101 GLY B1102 ASP B1103 SITE 1 AC2 23 GLY A 13 ALA A 15 SER A 19 ILE A 20 SITE 2 AC2 23 GLN A 40 CYS A 63 ASP A 64 VAL A 65 SITE 3 AC2 23 SER A 91 ILE A 92 GLY A 93 LEU A 144 SITE 4 AC2 23 SER A 145 LYS A 163 ALA A 189 GLY A 190 SITE 5 AC2 23 ILE A 192 THR A 194 ALA A 196 IDN A 302 SITE 6 AC2 23 HOH A 309 HOH A 368 HOH A 385 SITE 1 AC3 27 HOH B 2 HOH B 10 HOH B 35 HOH B 181 SITE 2 AC3 27 GLY B1013 ALA B1015 SER B1019 ILE B1020 SITE 3 AC3 27 GLN B1040 LEU B1044 CYS B1063 ASP B1064 SITE 4 AC3 27 VAL B1065 SER B1091 ILE B1092 GLY B1093 SITE 5 AC3 27 LEU B1144 SER B1145 TYR B1146 LYS B1163 SITE 6 AC3 27 ALA B1189 GLY B1190 PRO B1191 ILE B1192 SITE 7 AC3 27 THR B1194 ALA B1196 IDN B1302 SITE 1 AC4 10 PHE A 94 ALA A 95 TYR A 146 TYR A 156 SITE 2 AC4 10 MET A 159 ALA A 196 ILE A 200 LYS A 201 SITE 3 AC4 10 MET A 206 NAD A 301 SITE 1 AC5 10 PHE B1094 ALA B1095 TYR B1146 TYR B1156 SITE 2 AC5 10 MET B1159 ALA B1196 ILE B1200 LYS B1201 SITE 3 AC5 10 MET B1206 NAD B1301 CRYST1 79.600 79.600 325.480 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012563 0.007253 0.000000 0.00000 SCALE2 0.000000 0.014506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003072 0.00000 MASTER 371 0 5 32 14 0 21 6 0 0 0 42 END